Par Pharmaceutical Announces Fourth Quarter and Full Year 2013 Conference Call

Par Pharmaceutical's picture
Printer-friendly versionPrinter-friendly versionWoodcliff Lake, N.J., March 13, 2014 – Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, March 20, 2014 at 10:00 a.m. EDT to review its results of operations for the fourth quarter and full year ended December 31, 2013.  Par is privately held and currently makes certain financial information available to the public in its filings with the Securities and Exchange Commission.  Par will file its financial statements for the year ended December 31, 2013 with the SEC prior to the call.  Only holders of Par’s debt securities, certain prospective holders of Par’s debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call by requesting access to the secured area of Par’s website at for dial-in information.   About Par Pharmaceutical Companies Par Pharmaceutical Companies, Inc. is a privately-held, U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals.  For press release and other company information, visit

News Source : Par Pharmaceutical Announces Fourth Quarter and Full Year 2013 Conference Call

Copy this html code to your website/blog to embed this press release.


Post new comment

5 + 6 =

To prevent automated spam submissions leave this field empty.